The current Small Animal Radiation Research Platform (SARRP) is poor for localizing small soft tissue targets for irradiation or tumor models growing in a soft tissue environment. Therefore, an imaging method complementary to x-ray CT is required to localize the soft tissue target’s Center of Mass (CoM) to within 1 mm. In this paper, we report the development of an integrated x-ray/bioluminescence imaging/tomography (BLI/BLT) system to provide a pre-clinical, high resolution irradiation system. This system can be used to study radiation effects in small animals under the conebeam computed tomography (CBCT) imaging guidance by adding the bioluminescence imaging (BLI) system as a standalone system which can also be docked onto the SARRP. The proposed system integrates two robotic rotating stages and an x-ray source rated at maximum 130 kVp and having a small variable focal spot. A high performance and low noise CCD camera mounted in a light-tight housing along with an optical filter assembly is used for multiwavelength BL imaging and tomography. A three-mirror arrangement is implemented to eliminate the need of rotating the CCD camera for acquiring multiple views. The mirror system is attached to a motorized stage to capture images in angles between 0-90o (for the standalone system). C
S. Eslami ; Y. Yang ; J. Wong ; M. S. Patterson ; I. Iordachita
Download Paper
Radiation Research
Accuracy of off-line bioluminescence imaging to localize targets in preclinical radiation research
In this study, we investigated the accuracy of using off-line bioluminescence imaging (BLI) and tomography (BLT) to guide irradiation of small soft tissue targets on a small animal radiation research platform (SARRP) with on-board cone beam CT (CBCT) capability. A...
High throughput film dosimetry in homogeneous and heterogeneous media for a small animal irradiator
PURPOSE: We have established a high-throughput Gafchromic film dosimetry protocol for narrow kilo-voltage beams in homogeneous and heterogeneous media for small-animal radiotherapy applications. The kV beam characterization is based on extensive Gafchromic film...
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas
PURPOSE: Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults, and radiation is one of the main treatment modalities. However, cure rates remain low despite best available therapies. Immunotherapy is a promising modality that could work...
Comparing and evaluating the efficacy of the TOR18FG Leeds test X-ray phantom for T-rays.
The commercially available X-ray fluoroscopy quality assurance phantom, the Leeds test object TOR18FG, was found to be suitable to assess T-ray image quality in the range (0.1-0.4) THz at a depth of 0.5 cm. Previous to this only custom made phantoms, made especially...
Radiobiological Studies Using Gamma and X Rays
The research relates to possibly replacing 137CsCl irradiators used in radiobiological research involving cells in culture and small animals with an X-RAD 320 Unit (X-ray source[4]) with energies higher than for a typical X-ray irradiator. The objective of this...
Radiotherapy for achillodynia : results of a single-center prospective randomized dose-optimization trial
BACKGROUND AND PURPOSE: The aim of this study was to compare the efficacy of two different dose-fractionation schedules for radiotherapy of patients with achillodynia. PATIENTS AND METHODS: Between February 2006 and February 2010, 112 consecutive evaluable patients...
Efficacy of low-dose radiotherapy in painful gonarthritis: experiences from a retrospective East German bicenter study
PURPOSE: To evaluate the efficacy of low-dose radiotherapy in painful gonarthritis. METHODS: We assessed the medical records of 1037 patients with painful gonarthritis who had undergone low-dose radiotherapy between 1981 and 2008. The subjective patient perception of...
Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
Outcomes for poor-risk localized prostate cancers treated with radiation are still insufficient. Targeting the "non-oncogene" addiction or stress response machinery is an appealing strategy for cancer therapeutics. Heat-shock-protein-90 (Hsp90), an integral member of...